Vitalethine, made naturally in mammals from the amino acid L-cysteine and pantothenic acid is “vital” to healthy immune function. Laboratory researchers discovered the Vitaletheine Modulators and demonstrated promising control over cancer during animal studies supported in part by grants from the National Institutes of Health. Initial response rates of at least 90% were reported by two back-to-back articles in Cancer Research. Of laboratory mice injected with uniformly fatal melanoma and treated with un-optimized regimens of the Vitaletheine Modulators, 70% survived for normal lifetimes. Importantly, 100% survival rates were obtained in mice with NS-1 myeloma.
All current data indicates that the immune system is largely responsible for these responses in mice study models. This data combined with observations that responses of human leukocytes and mouse spleen leukocytes are virtually identical when using compounds structurally related to Vitalethine, means similar human responses can be expected.
A Publication of VitaleTherapeutics, Inc., A Non-Profit Health Research & Education Organization, ©2008 Vitalethine.org, all rights reserved.